Skip to content
Recall Observatory FDA recall evidence

Drug product

Meclizine Hydrochloride Tablets, USP, 12.5 mg Tablets, Packaged in a) 100 Ct Bottles (NDC: 49884-034-01) and b) 1000 Ct Bottles (NDC: 49884-034-10), Rx only. Par Pharmaceutical Companies, Inc., Spring Valley, NY 10977.

D-0233-2016

October 26, 2015

Class III

Product summary

Firm
Par Pharmaceutical Inc.
Event
Event 72476
Status
Terminated
Classification
Class III
Quantity
a) 162,385 Bottles; b) 6949 Bottles
Official record key
drug-enforcement:D-0233-2016

Official wording

Reason: Failed Impurities/Degradation Specifications: Out of specification for impurities.

Code information: a) Lot #: 24820001, Expiry: NOV 2015; Lot #: 25783601, Expiry: OCT 2016; Lot #: 25783801, Expiry: OCT 2016; Lot #: 26731201, Expiry: AUG 2017; Lot #: 26762002, Expiry: FEB 2018. b) Lot #: 26683201, Expiry: AUG 2017; Lot#: 26762001, Expiry: FEB 2018.

Distribution pattern: U.S. Nationwide including Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out of specification